Literature DB >> 29078990

Staging pancreatic carcinoma by computed tomography.

I Montejo Gañán1, L F Ángel Ríos2, L Sarría Octavio de Toledo2, M E Martínez Mombila2, L H Ros Mendoza2.   

Abstract

Pancreatic carcinoma is becoming more common in our environment; the mortality rate for this tumor has barely changed over the last 20 years. Early diagnosis and accurate staging are crucial to ensure an appropriate therapeutic approach, which should aim to improve survival in patients in whom complete resection is possible and to minimize surgical morbidity and mortality in those with a high risk of residual disease after the intervention. Various imaging techniques are used for tumor staging: multidetector computed tomography (CT), magnetic resonance imaging, positron emission tomography (PET)-CT, endoscopic ultrasound, and diagnostic laparoscopy. Currently, multidetector CT is the technique of choice for the study of pancreatic tumors; thus, this article aims to review the state of the art in staging adenocarcinoma of the pancreas, focusing mainly on the applications and limitations of this technique.
Copyright © 2017 SERAM. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma pancreático; Estadificación; Multidetector CT; Pancreatic adenocarcinoma; Staging; TC multidetector

Mesh:

Year:  2017        PMID: 29078990     DOI: 10.1016/j.rx.2017.08.004

Source DB:  PubMed          Journal:  Radiologia (Engl Ed)        ISSN: 2173-5107


  2 in total

1.  Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of PAX8/NOTCH1 signaling pathway.

Authors:  Chen Qi; Chen Xiaofeng; Li Dongen; Yang Liang; Xu Liping; Hu Yue; Jiang Jianshuai
Journal:  J Exp Clin Cancer Res       Date:  2019-08-07

2.  Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas.

Authors:  Manuel Röhrich; Patrick Naumann; Frederik L Giesel; Peter L Choyke; Fabian Staudinger; Annika Wefers; Dawn P Liew; Clemens Kratochwil; Hendrik Rathke; Jakob Liermann; Klaus Herfarth; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Matthias Lang; Stefan A Koerber
Journal:  J Nucl Med       Date:  2020-10-23       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.